… association between NE gene variants and response time variability measured at baseline
before MPH treatment in children with ADHD… and SNP variation across 10 candidate genes in …

… studies examining associations between candidate genes and … for MPH in 0–17-year-old
patients diagnosed with ADHD. … investigating stimulant treatment other than MPH (n = 7) were …

… gene variants associated with the etiology of ADHD also predicted medication response. …
affecting therapeutic effect of ADHD treated by optimal dose of methylphenidate [in Chinese]. …

… as one of the candidate genes associated with ADHD [11]. … range of 3-7 points; the dichotomous
response criterion was our … understand the role of genetic variation in a good vs. poor …

… gene in therapeutic response to MPH treatment, the aim of this investigation is to evaluate the
association between … and the clinical response to MPH in a sample of adults with ADHD. In …

… children with attention-deficit/hyperactivity disorder. Genotype data … candidate genes
queried based on prior research, our data supported a contribution of genetic variation in 7 genes …

… new possible candidate genes as well as potential gene–gene interactions … No significant
association between genetic variants in 7 candidate genes and response to methylphenidate …

… among patients regarding response to medication, required doses, and adverse events.
Pharmacotherapy with methylphenidate (MPH) seems to be the first-line treatment … the 4, 7 and 2 …

… CGI-S is a clinician-rated assessment in which scores vary from 1 (no symptoms) to 7 (… )
Association of ADHD with genetic variants in the 5′-region of the dopamine transporter gene: …

… stimulant drugs amphetamine and methylphenidate. Before 1997… to be major candidate
genes for childhood ADHD, although … genetic variants are more important for the maintenance of …